Rogier I. Versteeg
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 92 publications
Correction: Is cribriform pattern in prostate biopsy a risk factor for metastatic disease on 68Ga-PSMA-11 PET/CT?
Journal: World journal of urology
Published: September 21, 2023
MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma.
Journal: Frontiers in oncology
Published: December 22, 2022
Is cribriform pattern in prostate biopsy a risk factor for metastatic disease on 68Ga-PSMA-11 PET/CT?
Journal: World journal of urology
Published: December 21, 2022
Correction: Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors.
Journal: Cancer research
Published: July 18, 2022
A Common Genomic Denominator for Neuroblastoma and Differentiated Thyroid Carcinoma? A Case Series in Children.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: March 07, 2022
DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma.
Journal: JCI insight
Published: August 03, 2021
Defects in 8-oxo-guanine repair pathway cause high frequency of C > A substitutions in neuroblastoma.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 22, 2021
Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors.
Journal: Cancer research
Published: May 22, 2021
Last Updated: 09/26/2026